Valley National Advisers’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,000
| Closed | -$3K | – | 1001 |
|
|
2022
Q4 | $3K | Hold |
3,000
| – | – | ﹤0.01% | 724 |
|
|
2022
Q3 | $5K | Hold |
3,000
| – | – | ﹤0.01% | 691 |
|
|
2022
Q2 | $8K | Hold |
3,000
| – | – | ﹤0.01% | 610 |
|
|
2022
Q1 | $7K | Hold |
3,000
| – | – | ﹤0.01% | 663 |
|
|
2021
Q4 | $14K | Hold |
3,000
| – | – | ﹤0.01% | 558 |
|
|
2021
Q3 | $23K | Sell |
3,000
-2,059
| -41% | -$15.8K | ﹤0.01% | 467 |
|
|
2021
Q2 | $49K | Hold |
5,059
| – | – | 0.01% | 350 |
|
|
2021
Q1 | $42K | Sell |
5,059
-3,000
| -37% | -$24.9K | 0.01% | 348 |
|
|
2020
Q4 | $55K | Hold |
8,059
| – | – | 0.01% | 313 |
|
|
2020
Q3 | $90K | Buy |
8,059
+3,189
| +65% | +$35.6K | 0.02% | 237 |
|
|
2020
Q2 | $31K | Buy |
4,870
+670
| +16% | +$4.27K | 0.01% | 332 |
|
|
2020
Q1 | $8K | Buy |
4,200
+1,000
| +31% | +$1.91K | ﹤0.01% | 496 |
|
|
2019
Q4 | $11K | Hold |
3,200
| – | – | ﹤0.01% | 521 |
|
|
2019
Q3 | $7K | Buy |
+3,200
| New | +$7K | ﹤0.01% | 562 |
|